Head and neck masses are common in infants and children and can be congenital, inflammatory, and neoplastic. 1, 2 We present an infant with a right cheek mass diagnosed as isolated hemihyperplasia (IH) of the masseter who subsequently developed a rhabdomyosarcoma (RMS) and highlight the diagnostic challenges and treatment of this tumor.
A 19-week-old baby girl was referred for right cheek swelling present since birth. Her right cheek had become more noticeable over time, but she was otherwise healthy. Birth was at term and uneventful. Examination revealed a smooth, homogenous, firm right diffuse cheek swelling with no discreet mass or changes of overlying skin or buccal mucosa. No other abnormalities of the head and neck were noted. An ultrasound scan showed a 3.4 Â 1.2 cm noncystic mass. Magnetic resonance imaging (MRI) revealed an enlarged right masseter without abnormal enhancement, fluid collection, or edema. Computed tomography (CT) showed overgrowth of the right facial soft tissues without bony involvement (Figure 1) . A diagnosis of IH of the right masseter was made. Serum alpha-fetoprotein (AFP) and renal ultrasound were within normal limits, and yearly follow-up was recommended.
At 2 years, the child's mother reported a sudden increase in the size of the mass over a few weeks. Repeat CT confirmed a marked increase in the size of the mass with scalloping and bony changes of the ramus of the mandible and zygomatic arch. Magnetic resonance imaging revealed a heterogeneously enhancing soft tissue mass in the right masticator space, with extension into the infratemporal fossa (Figure 2 ). Positron emission tomography-computed tomography (PET-CT) scan showed no evidence of metastatic disease.
The mass was biopsied and revealed sheets of spindle cells with pleomorphic nuclei, numerous mitoses, and areas of focal necrosis staining positive for desmin and myogenin. A diagnosis of congenital spindle cell RMS was made. Chemotherapy and proton radiotherapy for localized control was given. The child completed 6 months of treatment with a decrease in the size of the mass and is expected to follow up with serial MRIs.
Rhabdomyosarcoma is a malignant neoplasm of undifferentiated muscle tissue. It is the most common soft tissue sarcoma in children, with an incidence of 0.4 per 100 000 children per year. 3 Up to 35% arise in the head and neck. 4 While most occur sporadically, RMS can be associated with certain genetic conditions that predispose to malignancy. The child presented above likely developed RMS arising from IH of the masseter, which is one of several overgrowth syndromes known to increase the risk of malignancy.
Isolated hemihyperplasia is a disorder of cell proliferation causing overgrowth of one or more regions of the body and may represent part of the clinical spectrum of BeckwithWiedemann syndrome. 5 Patients with IH have a 6% risk of developing an embryonal malignancy, 5 most commonly Wilms tumor (60%). 6 Rhabdomyosarcoma represents only 1.5% of reported malignancies related to IH. 6 Although no consensus tumor screening guidelines exist for IH, suggested surveillance includes periodic abdominal ultrasound with measurement of serum AFP and urine catecholamines for the first 4 to 7 years of life. 6 Computed tomography is useful to determine the degree of bony erosion or involvement and to evaluate extension to the skull base. Positron emission tomography-CT is used to detect nodal and metastatic disease.
Definitive diagnosis requires biopsy of the tumor. Treatment consists of a multimodality approach involving systemic chemotherapy and local control with surgery and/or radiation. Rhabdomyosarcoma should be in the differential diagnosis of a child with an enlarging head and neck mass.
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